Sakar Healthcare is trading 5.38% up at ₹972.90, with no clear company-specific catalyst identified.
- No October 21 company announcement surfaced; an exchange filing says a board meeting is scheduled for October 23 to consider financial results.
- Contemporaneous coverage reported healthcare leading U.S. sector gains amid investor rotation out of technology and into value stocks. This provides sector context but does not establish a direct cause for Sakar Healthcare’s rise.